Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
aTyr Pharma (LIFE)
NASDAQ:LIFE
aTyr Pharma (LIFE) Ownership - Who Owns aTyr Pharma?
1,717 Followers
aTyr Pharma (LIFE) Ownership Overview
2.72% Insiders
27.93% Mutual Funds
4.16% Other Institutional Investors
65.19% Public Companies and Individual Investors
The ownership structure of aTyr Pharma (LIFE) stock is a mix of institutional, retail and individual investors. Approximately 32.09% of the company’s stock is owned by Institutional Investors, 2.72% is owned by Insiders and 65.19% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Dec 12, 2023 | Sanjay Shukla President & Ceo,director | Bought | $17550 |
| Nov 13, 2023 | Sanjay Shukla President & Ceo,director | Bought | $16678 |
| Aug 01, 2023 | Sanjay Shukla President & Ceo,director | Bought | $30150 |
| May 11, 2023 | Paul Schimmel Director | Bought | $450000 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 10,049,000 | Institution | 14.83% | 15,776,930 | |
| 3,499,791 | Institution | 5.17% | 5,494,672 | |
| 2,536,244 | Institution | 3.74% | 3,981,903 | |
| 2,315,041 | Institution | 3.42% | 3,634,614 | |
| 2,258,063 | Institution | 3.33% | 3,545,159 | |
| 561,937 | Institution | 0.83% | 882,241 | |
| 148,456 | Institution | 0.22% | 233,076 | |
| 124,053 | Institution | 0.18% | 194,763 | |
| 57,812 | Institution | 0.09% | 90,765 | |
| 38,420 | Institution | 0.06% | 60,319 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 10,049,000 | Institution | 14.83% | 15,776,930 | |
| 3,499,791 | Institution | 5.17% | 5,494,672 | |
| 2,315,041 | Institution | 3.42% | 3,634,614 | |
| 2,258,063 | Institution | 3.33% | 3,545,159 | |
| 561,937 | Institution | 0.83% | 882,241 | |
| 148,456 | Institution | 0.22% | 233,076 | |
| 38,420 | Institution | 0.06% | 60,319 | |
| 26,689 | Institution | 0.04% | 41,902 | |
| 17,108 | Institution | 0.03% | 26,860 | |
| 8,468 | Institution | 0.01% | 13,295 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,748,835 | Institution | 2.58% | 3,410,228 | |
| 787,409 | Institution | 1.16% | 1,535,448 | |
| 124,053 | Institution | 0.18% | 200,966 | |
| 57,812 | Institution | 0.09% | 93,655 | |
| 6,340 | Institution | <0.01% | 10,271 | |
| 550 | Institution | <0.01% | 891 |
FAQ
Who Owns aTyr Pharma (LIFE)?
According to the latest TipRanks data, approximately 4.16% of the company's stock is held by institutional investors, 2.72% is held by insiders, and 65.19% is held by retail investors.
What percentage of aTyr Pharma (LIFE) stock is held by institutional investors?
According to the latest TipRanks data, approximately 4.16% of aTyr Pharma (LIFE) stock is held by institutional investors.
What percentage of aTyr Pharma (LIFE) stock is held by retail investors?
According to the latest TipRanks data, approximately 65.19% of aTyr Pharma (LIFE) stock is held by retail investors.
Who owns the most shares of aTyr Pharma (LIFE)?
Federated Hermes Equity Funds owns the most shares of aTyr Pharma (LIFE).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.